Use of pathology-specific peripheral blood CD34 thresholds to predict leukapheresis CD34 content with optimal accuracy: a bicentric analysis of 299 leukaphereses

Dobo, I.; Robillard, N.; Pineau, D.; Geneviève, F.; Piard, N.; Rapp, M.-J.; Boasson, M.; Zandecki, M.; Hermouet, S.
November 2001
Annals of Hematology;Nov2001, Vol. 80 Issue 11, p639
Academic Journal
CD34+ cell counts in peripheral blood (PB) and corresponding numbers of CD34+ cells and colony-forming units-granulocyte/macrophage (CFU-GM) in 299 leukapheresis products of 209 patients undergoing PB progenitor cell (PBPC) mobilization for autologous transplantation in two different centers were analyzed and compared according to diagnosis: non-Hodgkin lymphoma (NHL, 94 leukaphereses), multiple myeloma (MM, 75), Hodgkin's disease (HD, 37), solid tumors (35), and chronic myeloid leukemia (CML, 32). Without separating disease entities, correlations between PB CD34+ cell counts and leukapheresis content of CD34+ cells (r>0.83, P<0.01) and CFU-GM (r>0.81, P<0.01) were excellent. In both centers, a PB CD34 threshold ensuring a leukapheresis yield >106 CD34/kg was determined. This threshold was higher in center 1 than in center 2, and its predictive accuracy (91.4%, i.e., prediction correct 91.4% of the time) was significantly lower than in center 2 (98.4%, P=0.02). When data were analyzed by pathology, PB CD34+ cell counts and leukapheresis content of CD34+ cells and CFU-GM remained well correlated, and in both centers PB CD34 thresholds predictive of a yield >106 CD34/kg per leukapheresis could be determined for each pathology. For most patients, pathology-specific PB CD34 thresholds could be obtained directly from the equation of the PB CD34/leukapheresis CD34 correlation curve; they varied depending on both pathology and center (range: 7–20×106 CD34/l). Pathology-specific thresholds predicted a leukapheresis yield ≥106 CD34/kg accurately 100% of the time for MM patients in center 2 and HD and solid tumor patients of both centers, resulting in overall rates of accurate prediction of sufficient graft CD34 content of 96.6% in center 1 and 98.9% in center 2.


Related Articles

  • Emergency therapeutic leukapheresis in a case of acute myeloid leukemia M5. Ranganathan, Sudha; Sesikeran, Shyamala; Gupta, Vineet; Vanajakshi // Asian Journal of Transfusion Science;Jan-Jun2008, Vol. 2 Issue 1, p18 

    Cell separators in India are routinely used for plateletpheresis, peripheral blood stem cell collections and therapeutic plasma exchange. Therapeutic leukapheresis, particularly as an emergency procedure, has been uncommonly performed and reported. Here, a case of a 53-year-old male, diagnosed...

  • Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients. Carrasco, M.; Sureda, A.; Martínez, C.; Carmona, M.; Altés, A.; Martín-Henao, G.; Aventín, A.; Sierra, J. // Annals of Hematology;Dec2002, Vol. 81 Issue 12, p710 

    Conventional cytogenetic (CC) study and molecular analysis were performed in 150 leukapheresis products from 36 patients diagnosed with chronic myelogenous leukemia who were included in an autologous stem cell transplantation program. The aims of the study were to evaluate the effectiveness of...

  • Low CXCR4 membrane expression on CD34+ cells characterizes cells mobilized to blood. Dlubek, D.; Drabczak-Skrzypek, D.; Lange, A. // Bone Marrow Transplantation;Jan2006, Vol. 37 Issue 1, p19 

    In this work, association between the presence and membrane density of CXCR4 and the effectiveness of mobilization was studied. Ninety G-CSF mobilized PBPC and 28 native BM (nBM) preparations obtained from healthy individuals for transplantation and BM obtained after G-CSF mobilized PBPC...

  • Influence of preapheresis clinical factors on the efficiency of CD34+ cell collection by large-volume apheresis. Sarkodee-Adoo, C; Taran, I; Guo, C; Buadi, F; Murthy, R; Cox, E; Lopez, R; Westphal, S; Shope, S; O'Connell, B; Wethers, L; Meisenberg, B // Bone Marrow Transplantation;May2003, Vol. 31 Issue 10, p851 

    Summary:We evaluated 120 leukapheresis procedures (93 patients), in order to detect clinical factors that influence the efficiency of CD34+ collection using Cobe Spectra(tm) cell separators. Hematocrit was >27% and platelet count >30?000/ul in >95% of patients. Platelet transfusions were given...

  • Acute lower limb ischemia as the initial symptom of acute myeloid leukemia. Kafetzakis, Alexandros; Foundoulakis, Andreas; Ioannou, Christos V.; Stavroulaki, Emilia; Koutsopoulos, Anastassios; Katsamouris, Asterios N. // Vascular Medicine;2007, Vol. 12 Issue 3, p199 

    Although coagulatory system disorders are well recognized in patients with acute leukemia, these usually present with either hemorrhagic complications or thrombosis of small vessels. Large vessel thrombosis is a very rare clinical presentation. We present a patient with previously undiagnosed...

  • CD34 counts to predict the adequate collection of peripheral blood progenitor cells. Armitage, S; Hargreaves, R; Samson, D; Brennan, M; Kanfer, E; Navarrete, C // Bone Marrow Transplantation;10/1/97, Vol. 20 Issue 7, p587 

    An essential prerequisite for successful procurement of sufficient autologous peripheral blood progenitor cells (PBPC) for engraftment is the optimal timing of collection. A number of surrogate markers of peripheral blood progenitor cells were analysed to identify a single test which could...

  • Intravascular Lymphoma: The Oncologist’s "Great Imitator". Dan Zuckerman // Oncologist;May2006, Vol. 11 Issue 5, p496 

    Intravascular lymphoma (IVL) is a rare subtype of extranodal diffuse large B-cell lymphoma with a distinct presentation. Anatomically the disease is characterized by the proliferation of clonal lymphocytes within small vessels with relative sparing of the surrounding tissue. The clinical...

  • Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients. Bochennek, K.; Andreas, C.; Margraf, C.; Stahlkamp, H.; Zimmermann, S.; Esser, R.; Schwabe, D.; Klingebiel, T.; Grüttner, H.-P.; Koehl, U. // Bone Marrow Transplantation;Sep2005, Vol. 36 Issue 6, p481 

    Summary:In order to increase the CD34+ cell yield in children undergoing autologous stem cell transplantation, the optimum time of apheresis after G-CSF administration has still to be found. We prospectively studied the mobilization of CD34+ cells and white blood cells in the peripheral blood...

  • Detection of tumor cells in leukapheresis products from patients with breast cancer using immunocytochemical staining method. Yung Sheng Lin; Xiao Yan Zhong; Hohaus, Stephan; Kaul, Sepp; Haas, Rainer // Archives of Gynecology & Obstetrics;Feb2000, Vol. 263 Issue 3, p119 

    We used a combination of 4 monoclonal antibodies (BM7, BM8 against MUC1, 5D3 aganist CK8,18,19 and HEA125 against human epithelial antigen) and a sensitive immunocytochemical staining using cytospin preparation to identify breast tumor cells in leukapheresis products (LP). This assay allowed...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics